Ocoee, FL, September 30, 2016 – Rx30 is announcing a first to market, actionable pharmacogenetic platform through Alpha Genomix Laboratories that will allow the pharmacist and physician to work collaboratively towards a true personalized medicine approach within their communities. We have established an exclusive agreement with Alpha Genomix Laboratories, a leader in the field of precision medicine, to integrate an actionable, real-time approach to pharmacogenetics specifically for the independent pharmacist.
MAY 17, 2016 -- OCOEE, FL. -- Transaction Data Systems, Inc., doing business as Rx30 ("Rx30" or the "Company") announced today that it has completed the acquisition of Lagniappe Pharmacy Services ("LPS"). Rx30, headquartered in Ocoee, Florida, is a leading developer and supplier of pharmacy management software solutions to the independent retail, hospital, long-term care and specialty pharmacy markets.
Asembia (Formerly Armada Health Care) is pleased to announce a partnership with Rx30 for the integration of Asembia1 (Formerly ArmadaOne) with their pharmacy dispensing system.
Transaction Data Systems, Inc., doing business as Rx30, and DrFirst today announced that the companies are partnering to make secure communications and care collaboration software available to the independent pharmacy marketplace. Rx30, the leader in independent pharmacy management software, and DrFirst, a leader in e-medication management software and secure communications, will integrate DrFirst’s Backline platform within the Rx30 Pharmacy Management System.
Kingwood Pharmacy in East Ridge is always packed during the first weekend in November because that's when the 69-year-old pharmacy holds its annual Christmas open house. It's festive -- new products, refreshments and discounts abound.
With an uncertain regulatory landscape and declining reimbursement rates, most pharmacists would agree that it is tougher to be an independent pharmacist today than it was in years past. Asked to describe their challenges and concerns, pharmacists mentioned declining reimbursement rates for prescription drugs, mail-order use forced on patients, and the uncertainty surrounding healthcare regulation, among other issues.